Latest news
Iconovo signs an agreement with Stevanato Group regarding the manufacture, sale and distribution of ICOcap
The inhalation developer Iconovo AB (publ) announced today that the company has signed an agreement with the multinational Stevanato Group, headquartered…
Dr Orest Lastow is lecturing at Dry Powder Inhalers Annual Conference London 20-21 June 2018
The second generation of DPIs have become either established on the market or are a significant way along the approval process. These have been a great…
Press releases
Dec 14, 2021, 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Dec 14, 2021, 10:30
News
IR
English
Corporate Information
Other Corporate Information
Nov 19, 2021, 07:18
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Nov 19, 2021, 07:18
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Nov 15, 2021, 12:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 15, 2021, 12:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 01, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 01, 2021, 09:00
News
IR
English
Corporate Information
Other Corporate Information
Oct 29, 2021, 08:11
News
IR
English
Corporate Information
Other Corporate Information
Oct 28, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Sep 22, 2021, 15:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 20, 2021, 09:00
News
IR
English
Corporate Information
Other Corporate Information
Sep 20, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 15, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 26, 2021, 14:09
News
IR
English
Corporate Information
Other Corporate Information
Aug 26, 2021, 14:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 25, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 23, 2021, 11:04
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 12, 2021, 09:00
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
